Results 191 to 200 of about 14,298 (222)

Anti-GD2 Antibodies

2013
CHEUNG NAI-KONG, AHMED MAHIUDDIN
openaire   +8 more sources

Disialoganglioside GD2 as a therapeutic target for human diseases

Expert Opinion on Therapeutic Targets, 2015
Maya Suzuki
exaly  

Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

British Journal of Cancer, 2008
Barbara Carlini, Alberto Garaventa, Maria Valeria Corrias   +2 more
exaly  

Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults

Pediatric Blood and Cancer, 2016
Irène Cheung, Irina Ostrovnaya
exaly  

The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

British Journal of Cancer, 2012
Claudia Rossig, Bianca Altvater
exaly  

GD2 LIGANDS

2004
GAGNON MARTIN, SARAGOVI H URI
openaire   +2 more sources

ASC amino acid transporter 2, defined by enzyme‐mediated activation of radical sources, enhances malignancy of GD2‐positive small‐cell lung cancer

Cancer Science, 2018
Masahide Takahashi, Koichi Furukawa, Atsushi Enomoto   +2 more
exaly  

Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy

Pediatric and Developmental Pathology, 2018
Sabine Herblot, Hervé Sartelet, Pierre Teira   +2 more
exaly  

GD2 BINDING MOLECULE

2021
SHIKU HIROSHI, AKAHORI YASUSHI, MIWA HIROSHI, FUJIWARA HIROSHI, FURUKAWA KOICHI, FURUKAWA KEIKO, OHMI YUHSUKE   +6 more
openaire   +2 more sources

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas

Acta Neuropathologica, 1991
Darell Bigner, J E Mansson, P Fredman
exaly